| $350M | ||
| $241M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $448,044 | 4 | 36 |
Sells | $8,141,432 | 7 | 64 |
| Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | 1 | $136,463 | 0 | $0 | $136,463 |
| Aronson Martha Goldberg | President and CEO | 1 | $120,880 | 0 | $0 | $120,880 |
| Smith Christian Adam | Chief Commercial Officer | 1 | $99,186 | 0 | $0 | $99,186 |
| Parra Raul Jr. | CFO AND TREASURER | 1 | $91,515 | 0 | $0 | $91,515 |
| Peterson Neil W. | CHIEF OPERATING OFFICER | 0 | $0 | 3 | $2.95M | $-2.95M |
| Lampropoulos Fred P. | Executive Chairman | 0 | $0 | 4 | $5.19M | $-5.19M |
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
Over the last 12 months, insiders at Merit Medical Systems, Inc. have bought $448,044 and sold $8.14M worth of Merit Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Merit Medical Systems, Inc. have bought $448,044 and sold $10.73M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Voigt Michel J. (CHIEF HUMAN RESOURCES OFFICER) — $136,463. Aronson Martha Goldberg (President and CEO) — $120,880. Smith Christian Adam (Chief Commercial Officer) — $99,186.
The last purchase of 1,626 shares for transaction amount of $99,186 was made by Smith Christian Adam (Chief Commercial Officer) on 2026‑05‑11.
| 2026-08-24 | Sale | Peterson Neil W. | CHIEF OPERATING OFFICER | 7,500 0.0126% | $90.45 | $678,360 | -3.21% | |
| 2026-08-04 | Sale | Peterson Neil W. | CHIEF OPERATING OFFICER | 21,449 0.0356% | $85.00 | $1.82M | +3.75% | |
| 2026-05-11 | Smith Christian Adam | Chief Commercial Officer | 1,626 0.0028% | $61.00 | $99,186 | +41.55% | ||
| 2026-05-06 | Parra Raul Jr. | CFO AND TREASURER | 1,500 0.0025% | $61.01 | $91,515 | +38.42% | ||
| 2026-05-06 | Aronson Martha Goldberg | President and CEO | 2,000 0.0033% | $60.44 | $120,880 | +38.42% | ||
| 2026-05-05 | Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | 2,250 0.0038% | $60.65 | $136,463 | +41.05% | ||
| 2026-01-06 | Sale | Peterson Neil W. | CHIEF OPERATING OFFICER | 5,000 0.0085% | $90.00 | $450,000 | -15.24% | |
| 2025-11-25 | Sale | Lampropoulos Fred P. | Executive Chairman | 10,000 0.017% | $88.04 | $880,377 | -6.85% | |
| 2025-11-21 | Sale | Lampropoulos Fred P. | Executive Chairman | 25,000 0.0422% | $87.31 | $2.18M | -6.41% | |
| 2025-11-20 | Sale | Lampropoulos Fred P. | Executive Chairman | 20,000 0.0338% | $85.13 | $1.7M | -3.85% | |
| 2025-11-18 | Sale | Lampropoulos Fred P. | Executive Chairman | 5,000 0.0085% | $84.83 | $424,130 | -2.98% | |
| 2025-08-22 | Sale | Ward Lynne N. | director | 3,000 0.005% | $88.56 | $265,680 | -9.23% | |
| 2025-08-11 | Sale | Ward Lynne N. | director | 2,433 0.0041% | $84.89 | $206,536 | -3.27% | |
| 2025-06-13 | Sale | Parra Raul Jr. | CFO AND TREASURER | 15,181 0.0259% | $93.75 | $1.42M | -10.72% | |
| 2025-06-10 | Sale | Lampropoulos Fred P. | President and CEO | 400 0.0007% | $95.61 | $38,244 | -12.70% | |
| 2025-06-05 | Sale | Lampropoulos Fred P. | President and CEO | 10,000 0.0169% | $95.19 | $951,900 | -12.58% | |
| 2025-06-02 | Sale | McDonnell Michael R. | director | 1,750 0.003% | $94.51 | $165,393 | -11.01% | |
| 2025-05-30 | Sale | Lampropoulos Fred P. | President and CEO | 10,000 0.0169% | $95.12 | $951,200 | -12.25% | |
| 2025-05-30 | Sale | McDonnell Michael R. | director | 1,750 0.0029% | $94.30 | $165,025 | -12.25% | |
| 2025-05-30 | Sale | Floyd David | director | 3,515 0.0059% | $94.16 | $330,972 | -12.25% |
| Lampropoulos Fred P. | Executive Chairman | 1019955 1.7023% | $88.97M | 3 | 75 | +29.33% |
| Parra Raul Jr. | CFO AND TREASURER | 58843 0.0982% | $5.13M | 2 | 16 | +56.98% |
| Aronson Martha Goldberg | President and CEO | 49792 0.0831% | $4.34M | 1 | 0 | |
| Peterson Neil W. | CHIEF OPERATING OFFICER | 18051 0.0301% | $1.57M | 0 | 10 | |
| Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | 2265 0.0038% | $197,575.95 | 1 | 2 | |
| Smith Christian Adam | Chief Commercial Officer | 2220 0.0037% | $193,650.60 | 1 | 0 | |
| STANGER KENT W | director | 415087 0.6928% | $36.21M | 0 | 44 | |
| STILLABOWER MICHAEL E | director | 107868 0.18% | $9.41M | 0 | 15 | |
| ANDERSON A SCOTT | director | 49217 0.0821% | $4.29M | 0 | 8 | |
| Wright Joseph | CHIEF COMMERCIAL OFFICER | 42223 0.0705% | $3.68M | 0 | 8 | |
| Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY | 38945 0.065% | $3.4M | 0 | 8 | |
| Millner F. Ann | director | 34543 0.0577% | $3.01M | 0 | 9 | |
| Gunderson Thomas James | director | 19257 0.0321% | $1.68M | 0 | 1 | |
| Frost Ronald | CHIEF OPERATING OFFICER | 15144 0.0253% | $1.32M | 1 | 10 | <0.0001% |
| Ward Lynne N. | director | 12809 0.0214% | $1.12M | 0 | 4 | |
| Karras Nolan E. | director | 10500 0.0175% | $915,915.00 | 3 | 9 | +20.13% |
| PERRY RASHELLE | Chief Legal Officer | 9435 0.0157% | $823,015.05 | 2 | 12 | +21.69% |
| McDonnell Michael R. | director | 6395 0.0107% | $557,835.85 | 0 | 2 | |
| Anderson Jill | director | 6252 0.0104% | $545,361.96 | 0 | 1 | |
| EDELMAN RICHARD W | 6000 0.01% | $523,380.00 | 0 | 29 | ||
| Floyd David | director | 4880 0.0081% | $425,682.40 | 1 | 1 | +31.4% |
| Evans Stephen C. | director | 4657 0.0078% | $406,230.11 | 0 | 2 | |
| ELLIS JAMES J | director | 4251 0.0071% | $370,814.73 | 0 | 9 | |
| Miller Franklin J | director | 2334 0.0039% | $203,594.82 | 2 | 20 | <0.0001% |
| Lampropoulos Justin J. | PRESIDENT, EMEA | 2343 0.0039% | $204,379.89 | 0 | 4 | |
| Birkett Bernard | Chief Financial Officer | 1075 0.0018% | $93,772.25 | 0 | 1 | |
| BARNETT GREG L | Chief Accounting Officer | 1000 0.0017% | $87,230.00 | 0 | 17 | |
| Nelson Arlin D | Chief Operating Officer | 300 0.0005% | $26,169.00 | 0 | 3 | |
| BEAN REX C | director | 0 0% | $0 | 0 | 57 | |
| FERRAND BRIAN L | Director of Sales | 0 0% | $0 | 0 | 6 | |
| WEINTRAUB B LEIGH | COO | 0 0% | $0 | 0 | 12 | |
| Stephens Martin R | Executive V.P. of Sales | 0 0% | $0 | 1 | 7 | <0.0001% |
| LIU DAVID MING-TEH | director | 0 0% | $0 | 0 | 1 |
| Increased Positions | 241 | +64.61% | 7M | +11.65% |
| Decreased Positions | 167 | -44.77% | 6M | -9.94% |
| New Positions | 65 | New | 2M | New |
| Sold Out Positions | 46 | Sold Out | 2M | Sold Out |
| Total Postitions | 447 | +19.84% | 62M | +1.71% |
| Blackrock, Inc. | $752,144.00 | 14.75% | 8.7M | -14,872 | -0.17% | 2025-09-30 |
| Vanguard Group Inc | $574,325.00 | 11.26% | 6.64M | -185,798 | -2.72% | 2025-09-30 |
| State Street Corp | $190,068.00 | 3.73% | 2.2M | -19,843 | -0.89% | 2025-09-30 |
| Conestoga Capital Advisors, Llc | $188,916.00 | 3.7% | 2.19M | -26,324 | -1.19% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $159,337.00 | 3.12% | 1.84M | +23,736 | +1.3% | 2025-09-30 |
| Fmr Llc | $140,122.00 | 2.75% | 1.62M | -920,379 | -36.22% | 2025-09-30 |
| Maverick Capital Ltd | $139,203.00 | 2.73% | 1.61M | +230,806 | +16.73% | 2025-09-30 |
| Geode Capital Management, Llc | $125,521.00 | 2.46% | 1.45M | +14,554 | +1.01% | 2025-09-30 |
| Macquarie Group Ltd | $115,115.00 | 2.26% | 1.33M | -124,745 | -8.57% | 2025-09-30 |
| Wellington Management Group Llp | $107,242.00 | 2.1% | 1.24M | +980,823 | +377.7% | 2025-09-30 |